decisionhealth Newsletters, Part B News - 2016 Issue 4 (April)
Technology, tests, agreements among ways to help physicians spot potential opioid abuse
Subscribe or sign in to view the full article.
Article Overview
This article covers non-coding clinical guidance for practices responding to concerns about opioid misuse and overdose risk. It discusses the role of prescription monitoring systems, drug testing, behavioral health assessment, pharmacy lock-in approaches, quantity limits, and general red-flag awareness. The piece is aimed at physicians and practice staff involved in pain management, prescribing oversight, and patient risk mitigation, and it references CDC guidance and state-level monitoring programs.
Why This Topic Matters
Opioid prescribing remains a high-risk area for clinicians, and practices need current, practical ways to support safer prescribing while recognizing possible misuse. Understanding the broad categories of monitoring and assessment discussed here can help teams decide whether the full article is relevant to their workflow and compliance efforts.
What You Will Learn
- How prescription monitoring programs fit into opioid-risk oversight
- How periodic drug testing may be used in chronic pain management
- Why behavioral health assessment may be considered when abuse risk is suspected
- What general prescribing safeguards and warning signs are discussed for opioid management
Who Should Read This
- Physicians
- Pain management clinicians
- Primary care practices
- Clinical staff involved in prescribing oversight
- Practice administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com